Order Article Reprints

Lakomy T, Akhoundova D, Nilius H, Kronig M-N, Novak U, Daskalakis M, Bacher U, Pabst T. Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules. 2023; 13(2):382. https://doi.org/10.3390/biom13020382

Lakomy, Tim, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Ulrike Bacher, and Thomas Pabst. 2023. "Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome" Biomolecules 13, no. 2: 382. https://doi.org/10.3390/biom13020382

Lakomy, T., Akhoundova, D., Nilius, H., Kronig, M. -N., Novak, U., Daskalakis, M., Bacher, U., & Pabst, T. (2023). Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules, 13(2), 382. https://doi.org/10.3390/biom13020382